Last updated: February 12, 2021
Sponsor: Hams Hamed Abdelrahman
Overall Status: Active - Recruiting
Phase
N/A
Condition
Saliva And Salivary Gland Dysfunction
Dry Mouth
Treatment
N/AClinical Study ID
NCT04756986
Malic acid in xerostomia
Ages 35-50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with type 2 diabetes mellitus suffering from xerostomia.
- Patients aged between 35 and 50 years old.
- Glycated hemoglobin less than 7% (28) .
- Duration of diabetes mellitus not less than 4 years and not more than 8 years.
Exclusion
Exclusion Criteria:
- Patients receiving any drugs that cause hyposalivation like anti-hypertensive drugs.
- Patients with any systemic disease reported to produce hyposalivation (sjogren'ssyndrome, hepatitis c, rheumatoid arthritis and lupus erythematosus) (8).
- Patients receiving chemo-therapy and radio-therapy.
- Mouth breathers.
Study Design
Total Participants: 52
Study Start date:
January 01, 2021
Estimated Completion Date:
November 01, 2021
Study Description
Connect with a study center
Faculty of Dentistry, Alexandria University
Alexandria,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.